-
Antilipemic Agents
Goals:
- Lower LDL
- Raise HDL
- Possibly Lower VLDL
-
Atorvastatin
-
Class:
- HMG-CoA reductase inhibitors
-
MOA:
- Inhibits cholesterol synthesis within the liver by blocking HMG-CoA reductase from converting into Mevalonate
-
Indications:
- Hypercholesterolemia
- Primary & Secondary CV prevention
- Post MI Therapy
- DM/DMII
-
Adverse Effects:
- Myopathy/rhabodmyolysis
- Hepatotoxicity
- New onset DM (rare)
- Teratogenicity (Category X)
-
Nursing Considerations:
- Administer in evening
- Monitor LF and CK
- Pt education on contraception and myopathy
-
Colesevelam
-
Class:
- Bile-acid sequestrant
-
MOA:
- Binds to bile acids (in the GI tract) to prevent absorption and promote excretion
Result: LDL cholesterol reduction
-
Indications:
- Adjunctive therapy in hypercholesterolemia, often with statin medications
-
Adverse Effects:
-
GI
- Constipation
- Bloating
- Indigestion
- Nausea
-
Nursing Considerations:
-
Med interactions
-Decreases absorption
- Thiazides
- Digoxin
- Warfarin
- Administer other meds 1 hr before or 4 hrs after bile-acid sequestrant admin
- Increase fluids & fiber prior to administering laxatives
- Take with food and water
-
Gemfibrozil
-
Class:
- Fibric acid derivative (fibrate)
-
MOA:
- Lowers VLDLs levels to reduce TG levels, raises HDL, little to no effect on LDL
-
Indications:
- Hypertriglyceridemia
- Mixed dyslipidemia
-
Adverse Effects:
-
GI disturbance
- nausea
- ab pain
- diarrhea
- Risk of gallstones
- Myopathy/rhabdomyolysis
- Hepatotoxicity
-
Nursing Considerations:
-
Can increase anticoagulant effects in patients on warfarin
- monitor for bleeding and INR
- Periodic LFT
- Patient education on myopathy and gall stones
- Medical Acronyms